754 Logo (Mirtazapine 30 mg)
Pill with imprint 754 Logo is Beige, Round and has been identified as Mirtazapine 30 mg. It is supplied by Watson Laboratories, Inc..
Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 754 Logo
Mirtazapine
- Imprint
- 754 Logo
- Strength
- 30 mg
- Color
- Beige
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Tetracyclic antidepressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 62037-0754
More about mirtazapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1388 Reviews
- Drug class: tetracyclic antidepressants
- FDA Alerts (4)
Consumer resources
- Mirtazapine
- Mirtazapine Orally Disintegrating Tablets
- Mirtazapine Tablets
- Mirtazapine (Advanced Reading)
Other brands: Remeron, Remeron SolTab
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
